comparemela.com
  1. Home
  2. Live Updates
  3. Diffusing Alpha Emitters Radiation Therapy - Breaking News

Latest Breaking News On - Diffusing alpha emitters radiation therapy - Page 12 : comparemela.com

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has.

Israel generalUnited statesRob claarItzhak kelsonAlpha daYona keisariExchange commissionHealthcare capital corpTel aviv universityAlpha tau medical ltdAlpha tau medicalAlpha tauDiffusing alpha emitters radiation therapyTel avivHealthcare capitalBusiness combination

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has.

Israel generalUnited statesRob claarItzhak kelsonAlpha daYona keisariExchange commissionHealthcare capital corpTel aviv universityAlpha tau medical ltdAlpha tau medicalAlpha tauDiffusing alpha emitters radiation therapyTel avivHealthcare capitalBusiness combination

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has.

Israel generalUnited statesAron popovtzerItzhak kelsonAlpha daYona keisariExchange commissionHadassah medical centerPrnewswire alpha tau medical ltdHealthcare capital corpTel aviv universityAlpha tau medical ltdTau medicalBest overall responseAlpha tauRobert den

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective

/PRNewswire/ Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that its US.

Israel generalUnited statesItzhak kelsonAlpha daYona keisariExchange commissionPrnewswire alpha tau medical ltdHealthcare capital corpTel aviv universityAlpha tau medical ltdTau medicalBreakthrough device designationAlpha tauDiffusing alpha emitters radiation therapyTel avivHealthcare capital

Alpha Tau Receives FDA s Breakthrough Device Designation for the Treatment of Recurrent GBM

/PRNewswire/ Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received.

Israel generalUnited statesItzhak kelsonAlpha daYona keisariExchange commissionDrug administrationTel aviv universityAlpha tau medical ltdTau medicalBreakthrough device designationAlpha tauDevice designationDiffusing alpha emitters radiation therapyAlpha tau medicalTel aviv

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.